September 2015 Issue Table Of Contents

From The Editor

• What Is Required For Better Medical Research Participation?

Feature Articles

• Pfizer: A Pure Power Play For Innovative Pharma
• Preparing Sanofi For Post-Patent Cliff Product Launches
• Combination Cancer Immunotheapy: A 2015 Update

Capitol Perspectives

• New Focus On Abortion Could Result In Government Shutdown

Companies To Watch

• Corbus Pharmaceuticals

Deeper Dive

• It’s A Competitive Sport: Coming To Terms With Bio-Mania

Outsourcing Insights

• Advanced Technologies Cited As Essential For Clinical Trial Challenges

Inside The Industry

• How Social Media Might Be Sabotaging Your Clinical Trial
• A Behind-The-Scenes Look At The Patient Clinical Trial Experience
• Making Britain The “Fastest Place” For Pharma R&D Adoption
• What To Know When Implementing A Compassionate Use Program
• Investigating The Myths About Opening A Subsidiary In Japan

Industry Leader

• Quality In The Biologics Discovery And Development Continuum
• How Serialization Can Help Your Pharma Brand

Leadership Lessons

• The Light Touch: Are You A Boss Or A Leader

Ask The Board

• Ask The Board: What Is The greatest insight gained From Attending This Year’s BIO International conference?